These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37338371)

  • 1. Escherichia coli ST131 Associated with Increased Mortality in Bloodstream Infections from Urinary Tract Source.
    Brumwell A; Sutton G; Lantos PM; Hoffman K; Ruffin F; Brinkac L; Clarke TH; Adams MD; Fowler VG; Fouts DE; Thaden JT
    J Clin Microbiol; 2023 Jul; 61(7):e0019923. PubMed ID: 37338371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.
    Chung HC; Lai CH; Lin JN; Huang CK; Liang SH; Chen WF; Shih YC; Lin HH; Wang JL
    Antimicrob Agents Chemother; 2012 Feb; 56(2):618-22. PubMed ID: 22123694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-Spectrum-β-Lactamase- and Plasmid AmpC-Producing Escherichia coli Causing Community-Onset Bloodstream Infection: Association of Bacterial Clones and Virulence Genes with Septic Shock, Source of Infection, and Recurrence.
    Fröding I; Hasan B; Sylvin I; Coorens M; Nauclér P; Giske CG
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of Virulence Factors, Phylogenetic Group Features, and the Presence of ST131 Clone in Escherichia coli Isolates, a Urinary Tract Infection Agent in Children].
    Kılıç SG; Öcal D; Tekeli A; Dolapçı İ
    Mikrobiyol Bul; 2023 Oct; 57(4):535-552. PubMed ID: 37885384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic
    Shaik S; Ranjan A; Tiwari SK; Hussain A; Nandanwar N; Kumar N; Jadhav S; Semmler T; Baddam R; Islam MA; Alam M; Wieler LH; Watanabe H; Ahmed N
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066550
    [No Abstract]   [Full Text] [Related]  

  • 6. Bloodstream infection with extended-spectrum beta-lactamase-producing Escherichia coli: The role of virulence genes.
    Hung WT; Cheng MF; Tseng FC; Chen YS; Shin-Jung Lee S; Chang TH; Lin HH; Hung CH; Wang JL
    J Microbiol Immunol Infect; 2019 Dec; 52(6):947-955. PubMed ID: 31076319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.
    Olesen B; Hansen DS; Nilsson F; Frimodt-Møller J; Leihof RF; Struve C; Scheutz F; Johnston B; Krogfelt KA; Johnson JR
    J Clin Microbiol; 2013 Jun; 51(6):1779-85. PubMed ID: 23554186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates.
    Rodríguez I; Figueiredo AS; Sousa M; Aracil-Gisbert S; Fernández-de-Bobadilla MD; Lanza VF; Rodríguez C; Zamora J; Loza E; Mingo P; Brooks CJ; Cantón R; Baquero F; Coque TM
    mSphere; 2021 Dec; 6(6):e0086821. PubMed ID: 34935444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
    Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
    Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Escherichia coli Urine Isolates and Risk Factors for Secondary Bloodstream Infections in Patients with Urinary Tract Infections.
    Choi HJ; Jeong SH; Shin KS; Kim YA; Kim YR; Kim HS; Shin JH; Shin JH; Uh Y; Bae S; Yoon EJ; Yoo JS
    Microbiol Spectr; 2022 Aug; 10(4):e0166022. PubMed ID: 35862950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genotypic and phenotypic characteristics contributing to high virulence and antibiotics resistance in Escherichia coli O25-B2-ST131 in comparison to non- O25-B2-ST131.
    Shahbazi R; Salmanzadeh-Ahrabi S; Aslani MM; Alebouyeh M; Falahi J; Nikbin VS
    BMC Pediatr; 2023 Feb; 23(1):59. PubMed ID: 36737722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Enteroaggregative Escherichia coli within the ST131 Lineage as a Cause of Extraintestinal Infections.
    Boll EJ; Overballe-Petersen S; Hasman H; Roer L; Ng K; Scheutz F; Hammerum AM; Dungu A; Hansen F; Johannesen TB; Johnson A; Nair DT; Lilje B; Hansen DS; Krogfelt KA; Johnson TJ; Price LB; Johnson JR; Struve C; Olesen B; Stegger M
    mBio; 2020 May; 11(3):. PubMed ID: 32430467
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution of Pathogenicity Island Markers and H-Antigen Types of
    Rasoulinasab M; Shahcheraghi F; Feizabadi MM; Nikmanesh B; Hajihasani A; Sabeti S; Aslani MM
    Microb Drug Resist; 2021 Mar; 27(3):369-382. PubMed ID: 32716242
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
    Kim YA; Lee K; Chung JE
    BMC Infect Dis; 2018 Jun; 18(1):250. PubMed ID: 29859045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections.
    Hefzy EM; Hassuna NA
    Microb Drug Resist; 2017 Mar; 23(2):224-229. PubMed ID: 27214282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of O25b-ST131 clone, CTX-M-1 and CTX-M-15 genes via real-time PCR in Escherichia coli strains in patients with UTIs obtained from a university hospital in Istanbul.
    Demirci M; Ünlü Ö; İstanbullu Tosun A
    J Infect Public Health; 2019; 12(5):640-644. PubMed ID: 30826300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
    Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants.
    Cheng MF; Chen WL; Hung WY; Huang IF; Chiou YH; Chen YS; Lee SS; Hung CH; Wang JL
    Pediatr Infect Dis J; 2015 May; 34(5):469-75. PubMed ID: 25879646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of O25b-ST131
    Dziri O; Dziri R; Maraoub A; Chouchani C
    Microb Drug Resist; 2020 Jul; 26(7):741-746. PubMed ID: 31916915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.